Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Herpes Simplex Virus (HSV) Type-Specific IgG Antibodies

Test code(s) 6447, 3636X, 3640

A positive result strongly suggests a recent or past HSV infection. The person may be capable of transmitting the virus to others.

A small percentage of positive HSV-2 IgG results may be false-positive.1 Further testing may be appropriate for patients with a low or unexpected positive HSV-2 IgG result. The HSV-2 IgG Inhibition, ELISA performed at Quest Diagnostics Infectious Disease can be used to further characterize the sample and distinguish a false-positive from a true-positive result. Contact your local Quest Diagnostics laboratory to order this test.

Not necessarily. A negative result does not rule out infection, because the specimen may have been collected before antibodies reached detectable levels.2 This assay can detect HSV IgG antibodies as early as 3 weeks after the onset of symptoms.2 However, people seroconvert at different rates, and some do not seroconvert for 6 months or longer.2

Additionally, a very small percentage (0.2%) of HSV-2 isolates lack glycoprotein G (gG).3 When the infecting HSV isolate is gG deficient, a false-negative result may occur.

 

References

  1. Aurelian, L. Herpes simplex viruses. In: Specter S, and Lanoz GL, eds. Clinical Virology Manual. 2nd ed. New York: Elsevier; 1992:473-497.
  2. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis. 2003;30:310-314.
  3. Liljeqvist JA, Svennerholm B, Bergström T. Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies. J Clin Microbiol. 1999;37:2727-2718.

 

This FAQ is provided for informational purposes only and is not intended as medical advice. A clinician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

 

Document FAQS.118 Version: 0
Version 1 effective 03/24/2017 to present
Version 0 effective 12/02/2013 to 03/24/2017

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.